Rezolute RZLT
NASDAQ RZLT
$4.07 +0.05 (+1.24%)
At close: Nov 11, 2026 · 4:00 PM EST

Rezolute (RZLT) EBT Margin (2019 - 2020)

Updated

Rezolute's EBT Margin came in at -120666.67% for fiscal Q1 2021 (quarter ended Sep 30, 2020), down 49726.67 percentage points from the prior quarter.

Analysis

Rezolute (RZLT) EBT Margin (2019 - 2020) Analysis & Trends

Over the trailing twelve months to Sep 30, 2020, Rezolute reported EBT Margin of -20514.13%; for FY2020 (ended Jun 30, 2020), it was -10815.43%, up 39096.05 percentage points from FY2019.

  • Going back by fiscal year, EBT Margin was -49911.48% in FY2019.
  • The fiscal Q1 2021 figure represents the lowest quarterly EBT Margin since fiscal Q3 2019.
  • Business Quant data shows RZLT's EBT Margin at -70940.00% (Q4 2020), -16800.00% (Q3 2020) and -12344.44% (Q2 2020) in the three fiscal quarters before Q1 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.13%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 27.75%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 26.27%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 45.21%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.90%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 20.41%
10 Rezolute 388.82 Mn -62.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -120,666.67%
Jun 30, 2020 -70,940.00%
Mar 31, 2020 -16,800.00%
Dec 31, 2019 -12,344.44%
Jun 30, 2019 -15,169.00%
Mar 31, 2019 -142,232.00%
API Access

Rezolute EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=RZLT&period=max&api_key=YOUR_API_KEY